Medicines quality announcement of second 6 kinds of medicines and 28 batch are not up to standard

Medicines quality announcement of second 6 kinds of medicines and 28 batch are not up to standard
National Bureau of Drugs Supervision announced the medicines quality announcement of second of 2010 yesterday, to national basic medicine assortment Radix Notoginseng capsule nationwide, and great activates 11 preparation varieties such as pills and inspects by random samples quality. The result reveals, in 12 varieties and 2415 batch products inspected by random samples, there are 28 batch products that do not accord with the standard regulation in 6 kinds of sampling inspection medicines such as parenteral urine kinase, compound licorice root slice,etc..
National basic the intersection of medicine and the intersection of variety and the intersection of Radix Notoginseng and capsule that inspect by random samples, sample batch 189 together, involve 17 manufacturing enterprises, all accord with the standard regulation. In addition, in 11 preparation varieties inspected by random samples, preparation, oil lamp spend plain preparation, Fluorine preparation, compound the intersection of ammonia and the intersection of phenol and the intersection of alkane and the intersection of amine and preparation, bone, star of sand, Luo peptide parenteral solution inspect batch by random samples to be all qualified. Seven li would rather distribute preparations, sulphur general Luo parenteral solution, oral preparation, parenteral urine kinase, ginseng of compound licorice root invigorate the spleen pill, ginkgo blade wait during sampling inspection, find together 28 batch products are not up to standard. Including the intersection of Beijing and match grow parenteral the intersection of urine and kinase, the intersection of Zhangjiakou and the intersection of the Great Wall and the intersection of medicine company and compound the intersection of licorice root and block,etc. that Co., Ltd. produce that Pharmaceutcal Co., Ltd. produce. At present, regional medicine supervises the department to investigate and prosecute in accordance with the law, investigating and prosecuting the result will report to national Bureau of Drugs Supervision by the end of October. Medicines not up to standard involved, can log in in the national websites of Bureau of Drugs Supervision and consult.

|